InnovationRx: Regrowing Cartilage To Fix Damaged Knees And Ankles [Forbes]
Vericel Corporation (VCEL)
Last vericel corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vcel.com/investor-relations
Company Research
Source: Forbes
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here Forbes The 13th Annual Forbes Healthcare Summit is taking place on December 4th in New York City. Known for its unparalleled networking and on-stage breaking news, this summit surrounds you with top healthcare professionals, healthtech innovators, and business executives from leading healthcare, pharma, insurance and wellness companies. Here's just a few of the speakers who will be sharing their insights at the event: Judy Faulkner , Founder and CEO of Epic Stéphane Bancel , CEO of Moderna Eric Lefkofsky , Founder and CEO of Tempus Kate Ryder , Founder and CEO of Maven Clinic And many more! You can apply to attend by following this link . We hope to see you there. With Less Invasive Knee Procedure, Vericel CEO Says Company Is Poised For More Growth Vericel CEO Nick Colangelo Vericel Persistent knee pain is sometimes caused by damage to the cartilage that lines the
Show less
Read more
Impact Snapshot
Event Time:
VCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCEL alerts
High impacting Vericel Corporation news events
Weekly update
A roundup of the hottest topics
VCEL
News
- Vericel Co. (NASDAQ: VCEL) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Vericel Co. (NASDAQ: VCEL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.MarketBeat
- Vericel Corp (VCEL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic FDA ... [Yahoo! Finance]Yahoo! Finance
- Vericel Corporation (VCEL) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Vericel Reports Third Quarter 2024 Financial ResultsGlobeNewswire
VCEL
Earnings
- 11/7/24 - Beat
VCEL
Analyst Actions
- 11/8/24 - HC Wainwright
VCEL
Sec Filings
- 11/14/24 - Form 144
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- VCEL's page on the SEC website